The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure ...

Manufacturers have been asked to adopt risk-based approaches, including stricter testing protocols, revised storage ...

Drug regulator DCGI has asked drug controllers of all states and Union Territories to direct manufacturers under their ...

NDMA is classified as a Group 2A carcinogen by the International Agency for Research on Cancer (IARC), indicating it is a ...

The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a ...

Drug regulator DCGI has asked drug controllers of all states and Union Territories to direct manufacturers under their jurisdiction to monitor the presence of a potentially carcinogenic chemical — ...

Ranitidine, a commonly used medicine for acidity in India, is under the scanner. The Central Drugs Standard Control ...

An announcement from Incannex Healthcare Limited Sponsored ADR ( ($IXHL) ) is now available. On July 25, 2025, Incannex Healthcare Inc. announced ...

CDSCO is monitoring ranitidine due to NDMA, a potential carcinogen. The DTAB recommended a study on the drug's safety, ...

Many companies face FDA complete response letters due to ongoing chemistry, manufacturing, and controls, or CMC, and ...

JAMAICA Labour Party (JLP) standard-bearer for St Andrew North Central Delano Seiveright is spearheading a wave of ...